Skip to content

Impact of Exogenous Ketones on Indices of Keto-Adaptation in Obese Subjects on Weight Reducing Diets.

Strategies to Augment Ketosis: Impact of Exogenous Ketones on Indices of Keto-Adaptation in Obese Subjects on Weight Reducing Diets.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06449287
Acronym
STAK
Enrollment
37
Registered
2024-06-10
Start date
2018-07-05
Completion date
2019-08-21
Last updated
2024-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ketogenic Diet, Weight Loss

Keywords

ketones, metabolism, weight loss

Brief summary

This project will be a three-group controlled 6-wk feeding study where all meals are prepared and provided to obese participants. All participants will be fed a 25% energy-restricted diet. Two diets will be very low in carbohydrate (i.e., ketogenic diets) designed to induce nutritional ketosis and fat loss. Another diet will be low in fat and saturated fat but contain the same total calories. Participants will be randomly assigned to a Ketone Supplement group who are provided an exogenous pre-formed source of beta-hydroxybutyrate (BOHB) or a Control group that only receives the standard ketogenic diet. Randomization will be stratified based on insulin resistance, sex, and body composition to ensure balanced group assignment. Because of timing of recruitment (i.e., after most of the ketogenic groups have already completed the study), the low-fat group will not be randomized. Outcome measurements will be made at various intervals over the 6-wk intervention.

Detailed description

This project will be a three-group controlled 6-wk feeding study where all meals are prepared and provided to obese participants. All participants will be fed a 25% energy-restricted diet. Two diets will be very low in carbohydrate (i.e., ketogenic diets) designed to induce nutritional ketosis and fat loss. Another diet will be low in fat and saturated fat but contain the same total calories. Participants will be randomly assigned to a Ketone Supplement group (n=12) who are provided an exogenous pre-formed source of beta-hydroxybutyrate (BOHB) or a Control group (n=12) that only receives the standard ketogenic diet. Randomization will be stratified based on insulin resistance, sex, and body composition to ensure balanced group assignment. Because of timing of recruitment (i.e., after most of the ketogenic groups have already completed the study), the low-fat group will not be randomized. Outcome measurements will be made at various intervals over the 6-wk intervention. Key outcome variables will include: 1) Markers of Ketosis/Keto-Adaptation: a. Daily measures of BOHB (capillary blood) b. Fasting serum BOHB and total ketones (venous blood) c. Diurnal capillary blood ketones and urinary loss of BOHB and total ketones 2) Energy Balance and Body Composition: a. Body mass (scale) b. Whole body and regional composition (DXA) c. Nitrogen balance (daily nitrogen intake - 24-hr urinary nitrogen loss) d. Resting energy expenditure and substrate oxidation (indirect calorimetry) e. Adiposity (myocardial/epicardial fat, liver fat, visceral fat, skeletal muscle fat by MRI) f. Microbiome (stool collection to observe microbiota and the response to diet alteration) 3) Cognitive and Behavioral: a. Computer-based cognitive function (ANAM) b. Behavioral responses (surveys) 4) Cardio-Metabolic Risk: a. Metabolic panel b. Circulating lipid panel (total cholesterol, LDL-C, HDL-C, TG) c. Glucose, insulin, HOMA

Interventions

OTHERDiet

The diet intervention will start after all baseline testing is complete

BIOLOGICALBlood Draw

Blood samples will be collected biweekly.

Hand-held glucometer will be used daily to monitor dietary intervention adherence.

OTHERBody Composition

DEXA Scanning will be done pre-, mid-, and post- intervention.

BIOLOGICALUrine Analysis

24 hour urine collection will be done biweekly.

BEHAVIORALNeuropsychological Measures - ANAM

The first cognitive assessment will be done via Automated Neuropsychological Assessment Metrics (ANAM). This cognitive battery is a library of computer-based tests of domains including attention, concentration, reaction time, memory, processing speed, decision-making, and executive function.

Sponsors

Ohio State University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
21 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* BMI \>27 and =35 kg/m2

Exclusion criteria

* have diabetes, liver, kidney, or other metabolic or endocrine dysfunction, or using diabetic medications. * Currently consuming a low-carbohydrate diet * Weight loss of \>10% in past 6 months -Currently pregnant or nursing, or planning to become pregnant during the study * Major psychiatric disorder (e.g., schizophrenia, bipolar disorder) * Excessive alcohol intake (acute or chronic) defined as average consumption of 3 or more alcohol-containing beverages daily or consumption of more than 14 alcoholic beverages per week

Design outcomes

Primary

MeasureTime frameDescription
Fat Mass (kg)up to six weeksDEXA Scanning will be biweekly to assess fat mass
Cholesterol (mg/dl)up to six weeksFasting venous blood will be collected biweekly to measure cholesterol.
Insulin (mIU/L)up to six weeksFasting venous blood will be collected biweekly.
Glucose (mg/dL)up to six weeksFasting venous blood will be collected biweekly.
Lean Mass (kg)up to six weeksDEXA Scanning will be biweekly to assess lean mass
Daily Ketone/Glucose MonitoringUp to 6 weeksDaily fasting glucose/ketones will be assessed using capillary finger stick lancing. A small drop of blood will be obtained once daily, while fasting, using enzymatic strips fitted for a handheld analyzer (KetoMojo). All the data will be stored in the device's internal memory.

Secondary

MeasureTime frameDescription
Neuropsychological Outcome 1 - Visual Short Term Memory (Throughput)up to six weeksThe first cognitive assessment will be done via Automated Neuropsychological Assessment Metrics (ANAM). Measures verbal short-term memory by having the users memorize a set of characters and then indicate as single characters are presented on the screen whether the character was part of the memory set. Results are measured by throughput.
Neuropsychological Outcome 1 - Spatial Processing (Throughput)up to six weeksThe first cognitive assessment will be done via Automated Neuropsychological Assessment Metrics (ANAM). Measures visual spatial skills and mental rotation by having the users compare the equivalence of two 4-bar histograms, the first of which is displayed upright and the second of which is displayed after a 90° rotation either clockwise or counterclockwise. Results are measured by Throughput.
Urine Chemistriesup to 6 weeks24 hour urine will be collected biweekly and analyzed for urine chemistries
Neuropsychological Outcome 1 - Reaction time (Throughput)up to six weeksThe first cognitive assessment will be done via Automated Neuropsychological Assessment Metrics (ANAM). Measures SRT by presenting the user with a series of \* symbols to which they must respond as quickly as possible each time the symbol appears. Results are measured by throughput.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026